BIOAGE LABS, INC. Lessee, Operating Lease, Liability, to be Paid
BIOAGE LABS, INC. (BIOA) had Lessee, Operating Lease, Liability, to be Paid of $3.71 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue · last filed 2026-08-05
- 2026-06-30: Lessee, Operating Lease, Liability, to be Paid $3.71M.
- 2026-03-31: Lessee, Operating Lease, Liability, to be Paid $3.83M.
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid $3.95M.
- 2025-09-30: Lessee, Operating Lease, Liability, to be Paid $4.13M.
| Period end | Lessee, Operating Lease, Liability, to be Paid |
|---|---|
| 2026-06-30 | $3.71M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $3.83M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $3.95M 10-K · filed 2026-03-24 |
| 2025-09-30 | $4.13M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $4.36M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $4.56M 10-Q · filed 2025-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |